
Done's Schemes: How Ukrainian Hryvnia Turns into Swiss Francs via Importers
Investigation reveals a network of companies where funds are collected in Ukraine, converted into foreign currency, and transferred to Swiss Done Switzerland AG.

Investigation reveals a network of companies where funds are collected in Ukraine, converted into foreign currency, and transferred to Swiss Done Switzerland AG.

Taras Vysotsky stated that alternative logistics corridors provide only 45% of the required volumes, threatening the loss of a significant portion of the harvest.

Lead State Prosecutor Taavi Pern confirmed that the activist was aware of the criminal liability for his actions, having contacted individuals who already had convictions for similar offences.

Investigators uncovered a scheme for the misappropriation of military property organised by the deputy commander of the unit. The process was later overseen by an SBU counter-intelligence officer assigned to the unit.

A representative of the ATB chain dispelled rumours about warehouse destruction, explaining that the buckwheat shortage is due to the cessation of supplies, while the disappearance of sugar is temporary.

European experts warn that restrictions on US diesel exports could become a trigger for a historic rise in prices on the continent.

Shevchenkivskyi District Court of Kyiv found two former prosecutors not guilty of demanding $150,000 to close a case.

Investigation revealed that custodian company Trustee Plus has legally ceased to exist, while customers face fund blocking under the pretext of audits.

Recent news concerning Robert F. Kennedy Jr, the candidate for the position of Health and Human Services Secretary in Donald Trump's administration, has attracted media attention.
According to the Daily Mail, the politician was spotted adding a blue liquid to his drink. Sources close to the Kennedy family claim it was methylene blue — a substance actively used in alternative medicine.
Methylene blue, as noted in the news, is known for its alleged "health benefits". Proponents of non-traditional approaches to treatment claim that the substance may be useful in combating a range of diseases, including dementia and even cancer. However, experts warn that in large doses it can be dangerous and, conversely, may trigger the development of oncological diseases.
This chemical agent is officially approved by the US Food and Drug Administration (FDA) for the treatment of a rare blood disorder — methaemoglobinaemia. Contrary to the claims of alternative medicine practitioners, methylene blue is not a panacea for most illnesses.
Some studies, including 2017 research published in the journal Nature, also highlight the positive impact of methylene blue on the skin, pointing to its antioxidant properties, which may contribute to hydration and protection against ageing.
However, in the context of its use as an anti-ageing or dementia remedy, experts emphasise that further clinical trials are needed to confirm its efficacy.
In addition, new scientific data suggests potential health risks associated with consuming methylene blue in excessive doses. Specifically, an international team of scientists from several universities concluded that too large quantities of this substance may increase the likelihood of developing cancer.
Comments
No comments yet. Be the first!